CN103301074A - 一种甘草酸二铵肠溶微丸及其制备方法和制剂 - Google Patents
一种甘草酸二铵肠溶微丸及其制备方法和制剂 Download PDFInfo
- Publication number
- CN103301074A CN103301074A CN2013102467911A CN201310246791A CN103301074A CN 103301074 A CN103301074 A CN 103301074A CN 2013102467911 A CN2013102467911 A CN 2013102467911A CN 201310246791 A CN201310246791 A CN 201310246791A CN 103301074 A CN103301074 A CN 103301074A
- Authority
- CN
- China
- Prior art keywords
- diammonium glycyrrhizinate
- enteric coated
- micropill
- diammonium
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- SPPIIOPGDLITJE-VLQRKCJKSA-N diazanium;(2s,3s,4s,5r,6s)-6-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-5-[(2r,3r,4s,5s,6s)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-3,4-dihy Chemical compound N.N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O SPPIIOPGDLITJE-VLQRKCJKSA-N 0.000 title claims abstract description 104
- 238000002360 preparation method Methods 0.000 title claims abstract description 49
- 239000008188 pellet Substances 0.000 title claims abstract description 17
- 238000000576 coating method Methods 0.000 claims abstract description 47
- 239000011248 coating agent Substances 0.000 claims abstract description 46
- 239000000463 material Substances 0.000 claims abstract description 24
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 19
- 239000000853 adhesive Substances 0.000 claims abstract description 6
- 230000001070 adhesive effect Effects 0.000 claims abstract description 6
- 239000000047 product Substances 0.000 claims description 40
- 239000011230 binding agent Substances 0.000 claims description 39
- 229920002472 Starch Polymers 0.000 claims description 16
- 239000008107 starch Substances 0.000 claims description 16
- 235000019698 starch Nutrition 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 15
- 239000002775 capsule Substances 0.000 claims description 13
- 239000012467 final product Substances 0.000 claims description 11
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 10
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 10
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 10
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 8
- 239000007779 soft material Substances 0.000 claims description 8
- 229920001353 Dextrin Polymers 0.000 claims description 7
- 239000004375 Dextrin Substances 0.000 claims description 7
- 235000019425 dextrin Nutrition 0.000 claims description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 4
- 229960003943 hypromellose Drugs 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 235000011477 liquorice Nutrition 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims description 2
- 229940100467 polyvinyl acetate phthalate Drugs 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- 239000004408 titanium dioxide Substances 0.000 claims description 2
- 239000001069 triethyl citrate Substances 0.000 claims description 2
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims description 2
- 235000013769 triethyl citrate Nutrition 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 abstract description 18
- 239000003814 drug Substances 0.000 abstract description 10
- 210000004051 gastric juice Anatomy 0.000 abstract description 8
- 230000006378 damage Effects 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000012530 fluid Substances 0.000 description 13
- 238000001035 drying Methods 0.000 description 12
- 239000007921 spray Substances 0.000 description 12
- 238000009835 boiling Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 230000000968 intestinal effect Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000004088 simulation Methods 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 239000002702 enteric coating Substances 0.000 description 7
- 238000009505 enteric coating Methods 0.000 description 7
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 210000004211 gastric acid Anatomy 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000004568 cement Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000005213 imbibition Methods 0.000 description 2
- 230000031891 intestinal absorption Effects 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- VCNKUCWWHVTTBY-UHFFFAOYSA-N 18alpha-Oleanane Natural products C1CCC(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4CCC3C21C VCNKUCWWHVTTBY-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- SIOMFBXUIJKTMF-UHFFFAOYSA-N hypoglauterpenic acid Natural products C1CC(O)C(C)(C)C2=CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C SIOMFBXUIJKTMF-UHFFFAOYSA-N 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- BPAWXSVOAOLSRP-UHFFFAOYSA-N oleanane Natural products CCCCCCCCCCCCCCCC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5CC(C)(C)CCC5(C)C(O)CC34C)C1(C)C BPAWXSVOAOLSRP-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310246791.1A CN103301074B (zh) | 2013-06-20 | 2013-06-20 | 一种甘草酸二铵肠溶微丸及其制备方法和制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310246791.1A CN103301074B (zh) | 2013-06-20 | 2013-06-20 | 一种甘草酸二铵肠溶微丸及其制备方法和制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103301074A true CN103301074A (zh) | 2013-09-18 |
CN103301074B CN103301074B (zh) | 2015-04-22 |
Family
ID=49127084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310246791.1A Active CN103301074B (zh) | 2013-06-20 | 2013-06-20 | 一种甘草酸二铵肠溶微丸及其制备方法和制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103301074B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104288108A (zh) * | 2014-10-18 | 2015-01-21 | 山东世博金都药业有限公司 | 一种甘草酸二铵肠溶缓释微丸及其制备方法 |
CN105663063A (zh) * | 2016-02-26 | 2016-06-15 | 正大天晴药业集团股份有限公司 | 甘草酸二铵和恩替卡韦的复方微丸片及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102008492A (zh) * | 2006-12-29 | 2011-04-13 | 江苏正大天晴药业股份有限公司 | 甘草酸或其盐的口服药物组合物及其制备方法 |
-
2013
- 2013-06-20 CN CN201310246791.1A patent/CN103301074B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102008492A (zh) * | 2006-12-29 | 2011-04-13 | 江苏正大天晴药业股份有限公司 | 甘草酸或其盐的口服药物组合物及其制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104288108A (zh) * | 2014-10-18 | 2015-01-21 | 山东世博金都药业有限公司 | 一种甘草酸二铵肠溶缓释微丸及其制备方法 |
CN105663063A (zh) * | 2016-02-26 | 2016-06-15 | 正大天晴药业集团股份有限公司 | 甘草酸二铵和恩替卡韦的复方微丸片及其制备方法 |
CN105663063B (zh) * | 2016-02-26 | 2017-12-08 | 正大天晴药业集团股份有限公司 | 甘草酸二铵和恩替卡韦的复方微丸片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103301074B (zh) | 2015-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105456223B (zh) | 美沙拉秦缓释微丸及其制备方法和美沙拉秦缓释胶囊 | |
CN104000789A (zh) | 一种阿德福韦酯分散片及其制备方法 | |
CN109568284B (zh) | 一种替诺福韦艾拉酚胺肠溶片及其制备方法 | |
CN103301074B (zh) | 一种甘草酸二铵肠溶微丸及其制备方法和制剂 | |
CN1857285A (zh) | 一种用于治疗心脑血管疾病的胶囊及其制备方法和应用 | |
CN105582546B (zh) | 一种恩替卡韦磷脂复合物和甘草酸二铵的复方肠溶片剂 | |
CN112569190B (zh) | 一种白头翁皂苷b4的口服给药制剂及其制备方法 | |
CN103271907B (zh) | 一种小檗碱和二甲双胍的口服药物组合物及其制备方法 | |
CN105769872A (zh) | 一种快速溶出的枸橼酸莫沙必利组合物 | |
CN109646417A (zh) | 一种曲美他嗪缓释片及其制备方法 | |
CN103211999B (zh) | 一种治疗急慢性肝炎的缓释微丸及其制备方法和应用 | |
CN106880639A (zh) | 阿司匹林和维生素c复方肠溶片及其制备方法 | |
CN102579536A (zh) | 三七总皂苷肠溶制剂及其制备方法 | |
CN203677566U (zh) | 一种用于治疗幽门螺杆菌的双层片 | |
CN104721163A (zh) | 一种含有拉莫三嗪的缓释片剂及其制备方法 | |
CN104337783B (zh) | 一种卡培他滨片剂及其制备方法 | |
CN101081227B (zh) | 甘草酸二铵的组合物 | |
CN104758273A (zh) | 一种尿素微囊制剂及其制备方法 | |
CN104013634A (zh) | 含有阿司匹林肠溶部分与双嘧达莫速释部分的胶囊及制备方法 | |
CN103432082A (zh) | 氨基葡萄糖组合物及其制备方法 | |
CN113521067B (zh) | 一种法莫替丁葡萄糖酸锌制剂组合物及其制备方法 | |
CN108785273B (zh) | 一种恩替卡韦胶囊药物组合物及其制备方法 | |
CN204072820U (zh) | 一种用于治疗幽门螺杆菌的复方三层片 | |
CN102389396A (zh) | 盐酸吡格列酮固体分散体及其药用组合物、以及它们的制备方法及用途 | |
CN108379237A (zh) | 一种治疗泌尿道感染的药物微囊制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: CHENGDU HUANSHEN GROUP CO., LTD. Free format text: FORMER OWNER: CHENGDU BOCHUANG BICHENG MEDICAL TECHNOLOGY CO., LTD. Effective date: 20140523 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140523 Address after: 610041 Sichuan province Chengdu Tianfu Avenue high-tech incubator Park building B, floor 3, China Applicant after: Chengdu Huanshen Group Co., Ltd. Address before: 610041 room B6-502, No. 88 South Garden Road, Chengdu hi tech Zone, Sichuan, China Applicant before: Chengdu Bochuang Bicheng Medical Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 610000 Sichuan province Chengdu Tianfu Avenue high-tech incubator Park building B, floor 3, China Patentee after: Chengdu Thai Health Technology Group Limited by Share Ltd Address before: 610041 Sichuan province Chengdu Tianfu Avenue high-tech incubator Park building B, floor 3, China Patentee before: Huashen Group Co., Ltd., Chengdu |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 610000 No.101, floor 1, building 2, no.1168, Shuxin Avenue, hi tech Zone (West Zone), Chengdu City, Sichuan Province Patentee after: Chengdu Huashen Technology Group Co., Ltd Address before: 610000 Sichuan province Chengdu Tianfu Avenue high-tech incubator Park building B, floor 3, China Patentee before: Chengdu Taihe Health Technology Group Co.,Ltd. |